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ABSTRACT 
Digital microfluidic biochips (DMFBs) are revolutionary 
biomedical devices towards diagnostics and point-of-care 
applications; the chips provide the capability of performing wide 
ranges of biochemistry and laboratory procedures, offering various 
opportunities among which to mention are automation, 
miniaturization and cost-affordability of bioassays. There have 
been various digital microfluidic biochips architectures; the 
application-specific chips are mainly suited towards executing a 
predefined set of bioassays whereas the more flexible general-
purpose chips allow executing wide ranges of bioassays on the 
same architecture. Though more flexible in terms of performing 
various bioassays the general-purpose chips require more 
complicated designs compared with application-specific 
counterparts necessitating larger and more costly designs. This 
paper attempts to propose a general-purpose field-programmable 
pin-constrained DMFB design with improved characteristics in 
terms area-consumption, manufacturing cost and performance. 
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1. INTRODUCTION 
Digital microfluidic biochips (DMFBs) are modern generation of 
devices enabling a new paradigm in biochemistry/laboratory 
procedures and healthcare diagnostics. DMFBs offer various great 
opportunities never existed before all in one place; the most crucial 
advantages of DMFBs compared with prior methodologies include 
automation, miniaturization and cost-affordability.  The chips are 
capable of performing wide range of fluidic bioassays among 
which are the following: polymerase chain reaction (PCR) [1], in-
vitro diagnostics [2], protein-crystallization [3], and DNA 
computing [4]. 
DMFBs operate on the basis of manipulating fluid droplets with 
pico-liter to Nano-liter volumes on a 2D grid of electrodes. A 
typical DMFB consists of two (bottom and top) plates. The bottom 
plates consist of 2D array of electrodes on which the microfluidic 
operations are performed. The top plate comprises of single 
electrode spanning the bottom plate acting as the ground electrode. 
Both the top and bottom plates are coated with a dielectric layer 
(e.g. Parylene C) and a hydrophobic layer facilitating movement of 
droplets. Figure 1 (a) shows the cross-sectional view of a DMFB, 
further Figure 1 (b) illustrates the bottom plate of a DMFB with I/O 
reservoirs on the periphery of the array of electrodes. The droplets 
are sandwiched between the two plates. This is to facilitate 
movement of droplets the space between the top and bottom plates. 
 
 
Figure 1 (a) Cross-sectional and (b) top view of a DMFB.  
 
Over the course of past few years there have been numerous 
research articles on DMFB designs capable of general-purpose 
bioassay execution while at the same time lowering manufacturing 
costs. This study attempts to propose a low-cost general-purpose 
field-programmable DMFB design.  
The rest of paper is organized as follows: Section 2 reviews the 
technology, synthesis flow and fundamental operations of DMFBs. 
Section 3 provides literature review on previous and state-of-art 
DMFB designs. Section 4 presents the proposed low-cost 
performance-efficient pin-constrained DMFB design. Section 5 
provides analysis on hardware cost associated with manufacturing 
of DMFB designs. Finally, Section 6 concludes the paper. 
2. BACKGROUND  
2.1 Microfluidic Biochip Technology 
There are various technologies for actuation of droplets on Digital 
(droplet-based) microfluidic biochips. One approach is through 
electrowetting on dielectric (EWOD) phenomenon [4]; which 
refers to electromechanical actuation (wetting) of conductive fluids 
on a solid surface through electrical bias [5]. Accordingly, droplets 
are actuated by applying appropriate voltage levels to the electrode 
beneath the droplet; which in creates an electrical field over the 
droplet. Subsequently, the tension between the droplet and surface 
of the electrode is increased which is used towards actuation of 
droplets. 
Figure 1 illustrates the electrowetting on dielectric (EWOD) 
phenomenon. Recently, there have been alternative approaches to 
actuation of droplets in droplet-based microfluidic biochips. One 
such alternative approach is tilting DMFB [6]; which utilizes 
stepper motors towards mechanical agitation of droplets. Another 
alternative approach to EWoD-based DMFBs is through magnetic 
actuation of floating liquid marbles [7]. 
Filler Fluid
Electrode Electrode Electrode
Ground Electrode
Sp
ac
er
Droplet
Dielectric 
Layer
Hydrophobic
 Layer
(a) (b)
Electrowetting
Electrode
Dispensing 
Port
I1
I2
O1
2.2 Fundamental DMFB Operations 
Every bioassay consists of various microfluidic operations, such as 
temporary storing (holding) the droplet in place, Droplet 
transportation, mixing of different samples, dispense (sample 
introduction), merging and splitting. Many bioassays require 
thermal cycling, fluorescence detection and etc. These operations 
demand special equipment which must be accounted for during the 
design and manufacturing processes of the DMFB. An example 
would be an external thermal measurement module for microfluidic 
devices. 
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Figure 2 Microfluidic operations 
2.3 Fluidic Level Synthesis 
Accomplishment of bioassays on a typical DMFB involves various 
input and synthesis stages. The process is commenced with 
inputting bioassay protocol and architecture specification files. 
The bioassay protocol incorporates data on how the bioassay is 
performed; which is in the form of a directed acyclic graph (DAG) 
of various operations involved in the protocol. The architecture 
specification file includes various data concerning the size of array 
of electrodes, location of I/O reservoirs on the periphery of the chip, 
location specific-purpose modules (e.g. detection, heating) within 
the array of electrodes and etc. Given the protocol and architecture 
specification files the synthesis flow is started and passes through 
various stages, Scheduling, Placement, and Droplet Routing. 
Figure 3 depicts synthesis flow of a typical DMFB. 
Initially, given the information of bioassay protocol and 
architecture specification files the scheduler algorithm attempts to 
assign exact start and end times to every operation within the 
bioassay protocol. This is directly proportional to the size of array 
of electrodes and the number of available resources to be allocated 
towards scheduling process. 
The scheduler is responsible for making the best use of available 
resources thus producing the shortest schedule for the bioassay. 
While attempting to schedule as many operations as possible during 
any single time-step the scheduler must ensure that the 
dependencies between operations are met. 
The placer algorithm attempts to place scheduled operation onto the 
array of electrodes given the availability of resources. The placer 
must attempt to place as many scheduled operations as possible so 
that all operations scheduled during any given time-step are 
successfully placed. Given successful placement of operations next 
the droplet routing stage accounts for routing of droplets onto the 
surface of the array of electrodes. The stage incorporates routing of 
droplets from input reservoirs on the periphery of the chip to 
modules, between the modules and from modules to output 
reservoirs on the periphery of the chip. 
2.4 Chip Level Design 
Given scheduling, placement and droplet routing stages the pin-
mapping and wire routing stages are optional stages towards 
reduced manufacturing costs. Early generation of DMFBs devoted 
a dedicated pin per single electrode namely called direct-addressing 
scheme; in which an array of size m ´  n requires m + n control pins. 
The direct-addressing scheme incurres higher manufacturing costs 
compared with other approaches. 
 
Figure 3 Synthesis flow of a typical digital microfluidic biochip 
(I denotes input, O denotes output reservoirs, and M represents 
mixing operations) 
Another alternative is cross-referencing scheme which assigns a 
dedicated control pin per distinct row and column; thus, an array of 
size m ´ n would require m + n control pins. Although requiring 
significantly lower number of control pins than the direct-
addressing scheme yet the approaches requires careful control over 
electrode actuations as concurrent activation of several rows and 
columns might cause unintended droplet movement. 
A more promising approach is active-matrix scheme which requires 
m + n control pins for addressing an array of size m ´ n; the 
approach eliminates the challenge of unintended droplet movement 
associated with the cross-referencing scheme while at the same 
time providing high degree of flexibility in terms of droplet 
movement comparable with direct-addressing scheme. Yet, given 
the significantly lower number of control pins the manufacturing 
costs are remarkably reduced. 
A handier approach is pin-constrained scheme; as the name implies 
the scheme constrains the number of control pins thus considerably 
reducing the manufacturing costs compared with the direct-
addressing scheme. The pin-constrained scheme is achieved by 
initially determining electrodes with equal functionalities; then the 
electrodes are grouped together, and a single control pin is devoted 
to the group of electrodes. Though, the manufacturing costs are 
reduced considerably the scheme suffers lower flexibility in terms 
of concurrent movement of droplets. 
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According to the chip architecture, there are two types of placement 
algorithms; namely, free and fixed placement algorithms. In case 
of free placement algorithms the placer is responsible for searching 
for free spaces on the array of electrodes and then assigning the 
operation with enough free space; whereas in case of fixed 
placement algorithms the location of modules (where operations 
are performed) is already fixed and the placer solely binds the 
operations to the first available location (module), given the type of 
resource required by the operation. 
Given the type of placement algorithm, free or fixed placement, the 
routing stage would be different. In case of free placement, it is 
might happen that modules are placed such that there are no routing 
paths for routing droplets into and out of some modules. In such a 
case the droplet routing stage fails and as a solution the placement 
stage must be modified such that possible deadlocks and blockages 
are eliminated; then, the droplet routing stage is attempted again. In 
case of fixed placement algorithm as the location of modules is 
fixed apriori there are dedicated droplet routing paths and 
subsequently there would be no deadlocks and blockages 
Wire routing stage assigns routes to conduction wires between the 
control pins and the signal pads with a total minimum wire length. 
3. RELATED WORK 
This section briefly reviews prior works on various DMFB designs 
and architectures; there have been various assay-specific/multi-
function DMFB designs yet for the sake of this study only field-
programmable general-purpose DMFB designs will be reviewed. 
Grissom et al. [8] proposed their field-programmable pin-
constrained (FPPC) design towards general-purpose bioassay 
execution. Also, Grissom et al. [10] proposed an enhanced version 
of their field-programmable pin-constrained design, namely 
EFPPC, aimed at reduced manufacturing costs. 
Keszocze et al. [9] proposed their DMFB synthesis flow based on 
general and exact routing methodology; producing DMFB designs 
with significantly low number of control pins. Yet, their proposed 
method computationally intensive and feasible in case of small and 
medium size bioassys. 
Wille et al. [11] one-pass synthesis scheme; resulting in much faster 
computation times compared with Keszocze et al. [9] which in turn 
allows for performing large bioassays such as protein bioassay. 
Yet, produced result by their synthesis flow is approximate and 
highly variable among different runs. 
Abdoli et al. [12][13] proposed their general-purpose file-
programmable pin-constrained (GFPC) design and its fault-tolerant 
variant primarily aimed at improved overall bioassay completion 
times and higher degree of fault-tolerance [14]. They presented 
their improved version of general-purpose field-programmable pin-
constrained (EGFPC) design aimed at reducing overall 
manufacturing costs while retaining competitive performance with 
prior designs [15]. 
Also, Abdoli et al. [16] proposed cell-based field-programmable 
pin-constrained designs inspired by field-programmable logic array 
(FPGA) devices. 
4. THE PROPOSED DESIGN  
Figure 4 illustrates the proposed DMFB design; as can be seen, the 
design incorporates three droplet routing paths along with 4 mixing 
modules and 8 storage/split/detection (SSD) modules. 
As illustrated in Figure 3 the proposed DMFB design consists of 
three droplet routing paths; routing paths utilize 3-phase routing 
\cite{srinivasan04}, which simply means only three pins are used 
for a distinct routing path. Subsequently, pins 1-9 are devoted to 
vertical left, horizontal and vertical right droplet routing paths. 
The proposed DMFB is designed such that SSD modules are 
integrated into mixing modules; every mixing module 
accommodates 2 SSD modules at the top left and right corners of 
the mixing module. Also, mixing modules above and below the 
horizontal droplet routing path require separate groups of control 
pins; which is towards reduced overall manufacturing costs. 
 
Figure 4. The proposed low-cost performance-efficient pin-
constrained (LFPC) DMFB design 
The I/O reservoirs are located on the left and right side of the array 
of electrodes. During the process of moving input droplets from I/O 
reservoirs to modules initially, droplets are dispensed from 
left/right I/O reservoirs and moved along the left/right vertical 
routing paths towards the horizontal routing path; then droplets are 
moved along the horizontal routing path till reaching below the I/O 
pin of the intended mixing/SDD module. Then, the droplet is 
moved up towards the I/O pin on the intended module; 
subsequently, the droplet is moved onto the I/O electrode. 
Eventually the droplet is moved to the hold electrode. 
Similarly, the same process applies to movement of droplets 
between mixing/SSD modules; in which initially, the droplet is 
moved out of the source module through the I/O pin and to the 
horizontal routing path. Then the droplet is moved along the 
horizontal routing path till reaching I/O pin of the destination 
module. Finally, the droplet is moved towards the I/O electrode and 
then to the hold electrode. The process of moving droplets from 
mixing/SSD modules to output reservoirs is reverse of the input 
process; firstly, the droplet is moved out of the module to the 
horizontal routing path. 
Given the location of output reservoirs on the left or right periphery 
of the array of electrodes the droplet is moved to appropriate 
left/right vertical routing path. Eventually, droplet is moved along 
the vertical routing path to reach the intended I/O reservoir. 
5. Hardware Analysis 
This section introduces parameters affecting the overall 
manufacturing cost of a typical DMFB; the primary focus of this 
section is to provide detailed cost analysis on wire routing costs of 
various field-programmable pin-constrained DMFB designs. The 
key parameters of DMFB wire routing costs include: 
• Dimensions of the array of electrodes (Electrode size) 
• Number of PCB metal-layers 
• Pin-count 
Early generation of field-programmable pin-constrained DMFB 
designs solely focused on general-purpose bioassay execution 
along with pin-counts as low as possible. Lower pin-count would 
eliminate the need for additional circuitry for driving control pins; 
yet sometimes it meant more complex wire routing and higher 
number of PCB metal layers. Figure 4 depicts wire routing of the 
proposed low-cost field-programmable pin-constrained DMFB 
design; as can be seen, the design solely requires one single PCB 
metal-layer which can greatly reduce the overall wire routing costs. 
 
Figure 4. Wire routing of the proposed low-cost field-
programmable pin-constrained DMFB design  
Figure 5 shows the wire routing of enhanced GFPC design 
(EGFPC) which applies various improvements over the original 
GFPC design to reduce the number of metal-layers towards wire 
routing; among which are updated pin-mapping for shared pins 
inside mixing modules, omission of vertical droplet routing paths 
in between the mixing modules. 
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Figure 5. Wire-routing of the enhanced GFPC architecture with 
orthogonal capacity of 2. 
6. CONCLUSION 
The wire-routing cost of a DMFB is directly affected by the cost of 
PCB metal layers plus the cost of additional circuitry; using larger 
feature sizes tends to reduce the PCB cost in terms of the number 
of PCB metal-layers. 
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